A Public-Health-Based Vision for the Management and Regulation of Psychedelics.
Mark Haden, Brian Emerson, Kenneth W. Tupper
Journal of Psychoactive Drugs 2016 DOI: 10.1080/02791072.2016.1202459 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Drug policy Drug regulation Psychedelic Psychoactive Public health |
| Key points | Proposes a public-health-based regulatory model for psychedelics that includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation. |
Abstract
The Health Officers Council of British Columbia has proposed post-prohibition regulatory models for currently illegal drugs based on public health principles, and this article continues this work by proposing a model for the regulation and management of psychedelics. This article outlines recent research on psychedelic substances and the key determinants of benefit and harm from their use. It then describes a public-health-based model for the regulation of psychedelics, which includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation.
Citations in the library
Cited by 13
- Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy Drug Science, Policy and Law 2017
- Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD) Journal of Psychopharmacology June 7, 2022
- Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead Frontiers in Psychiatry November 4, 2021
- Set and setting in microdosing: an oft-overlooked principle. Psychopharmacology December 1, 2022
- Emerging Psychedelic-Assisted Therapies: Implications for Nursing Practice Journal of Mental Health and Addiction Nursing February 19, 2020
and 8 more in the library
Cites 43
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 38 more in the library